Financial aspects of sentinel lymph node biopsy in early breast cancer.
OBJECTIVE
At present, early breast cancer is treated with conservative surgery of the primary lesion (BCS) along with axillary staging by sentinel lymph node biopsy (SLNB). Although the scintigraphic method is standardized, its surgical application is different for patient compliance, work organization, costs, and diagnosis related group (DRG) reimbursements.


METHODS
We compared four surgical protocols presently used in our region: (A) traditional BCS with axillary lymph node dissection (ALND); (B) BCS with SLNB and concomitant ALND for positive sentinel nodes (SN); (C) BCS and SLNB under local anaesthesia with subsequent ALND under general anaesthesia according to the SN result; (D) SLNB under local anaesthesia with subsequent BCS under local anaesthesia for negative SN, or ALND under general anaesthesia for positive SN. For each protocol, patient compliance, use of consumables, resources and time spent by various dedicated professionals, were analyzed. Furthermore, a detailed breakdown of 1-/2-day hospitalization costs was calculated using specific DRGs.


RESULTS
We reported a mean costs variation that ranged from 1,634 to 2,221 Euros (protocols C and D). The number of procedures performed and the pathologists' results are the most significant variables affecting the rate of DRG reimbursements, that were the highest for protocol D and the lowest for protocol B.


CONCLUSIONS
In our experience protocol C is the most suitable in terms of patient compliance, impact of surgical procedures, and work organization, and is granted by an appropriate DRG. We observed that a multidisciplinary approach enhances overall patient care and that a revaluation of DRG reimbursements is opportune.
Department of Radiometabolic Medicine, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy.
S
S
Severi
E
E
Gazzoni
A
A
Pellegrini
M
M
Sansovini
G
G
Raulli
C
C
Corbelli
M
M
Altini
G
G
Paganelli
D000768:Anesthesia, General; D000772:Anesthesia, Local; D001365:Axilla; D001943:Breast Neoplasms / Q000191:economics* / Q000473:pathology / Q000601:surgery; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D007558:Italy; D008197:Lymph Node Excision; D061305:Lymphoscintigraphy; D015412:Mastectomy, Segmental; D021701:Sentinel Lymph Node Biopsy / Q000191:economics*